Butterfly Network To Present At The 39th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Butterfly Network, an innovative digital health company, is set to present at the 39th Annual J.P. Morgan Healthcare Conference on January 12, 2021, at 9:30 AM ET. The company will discuss its plans to enhance access to ultrasound technology. Butterfly Network will be listed on the NYSE under the ticker BFLY following a merger with Longview Acquisition Corp (NYSE: LGVW). The leadership team, including CEO Laurent Faracci and CMO Dr. John Martin, aims to democratize medical imaging globally, particularly for the 4.7 billion people currently lacking ultrasound access.

GUILFORD, Conn., Jan. 11, 2021 /PRNewswire/ -- Butterfly Network, Inc., an innovative digital health company that is working to enable universal access to superior medical imaging, will present virtually at the 39^th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021, at 9:30 AM Eastern Time.

Butterfly Network announced in November that it will be listed on the New York Stock Exchange as BFLY in 2021 via a special purpose acquisition company merger (SPAC) with Longview Capital (NYSE: LGVW, expected to be NYSE: BFLY).

Butterfly's Chief Executive Officer, Laurent Faracci, will be joined by Dr. John Martin, Chief Medical Officer; Gioel Molinari, President; and Stephanie Fielding, Chief Financial Officer, to discuss how Butterfly plans to fundamentally improve the access and portability of ultrasound technology.

The presentation by members of the leadership team may be accessed on Butterfly's website at www.butterflynetwork.com/investors. An archived version of the webcast will be available for at least 30 days.

About Butterfly Network

Founded by Dr. Jonathan Rothberg in 2011 and led by CEO Laurent Faracci, Butterfly has created the world's first handheld, single-probe whole-body ultrasound system, Butterfly iQ. Butterfly Network's mission is to enable universal access to superior medical imaging, making high-quality ultrasound affordable, easy-to-use, globally accessible, and intelligently connected, including for the 4.7 billion people around the world lacking access to ultrasound. Through its proprietary Ultrasound-On-Chip™ technology, Butterfly Network is paving the way for earlier detection and remote management of health conditions around the world.  The Butterfly iQ can be purchased online today by healthcare practitioners in the United States, Australia, Belgium, Canada, Denmark, Finland, Germany, Ireland, Italy, the Netherlands, New Zealand, Norway, Poland, Portugal, Spain, Sweden, Switzerland, and the United Kingdom.

Contact Information:

Investor Relations
investors@butterflynetwork.com

Media Relations
media@butterflynetinc.com

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/butterfly-network-to-present-at-the-39th-annual-jp-morgan-healthcare-conference-301204881.html

SOURCE Butterfly Network

FAQ

What is Butterfly Network's stock symbol after its merger?

Butterfly Network will be listed as BFLY after its merger with Longview Acquisition Corp (NYSE: LGVW).

When is Butterfly Network's presentation at the J.P. Morgan Healthcare Conference?

Butterfly Network's presentation is on January 12, 2021, at 9:30 AM Eastern Time.

Who will present at the J.P. Morgan Healthcare Conference for Butterfly Network?

CEO Laurent Faracci, CMO Dr. John Martin, President Gioel Molinari, and CFO Stephanie Fielding will present.

What is the mission of Butterfly Network?

Butterfly Network's mission is to enable universal access to superior medical imaging, making ultrasound affordable and accessible globally.

How does Butterfly Network aim to improve ultrasound technology access?

Butterfly Network leverages its proprietary Ultrasound-On-Chip™ technology to enhance the portability and accessibility of ultrasound.